Tagged with Spain

Spain Aurora Berra, general manager of Sobi Spain and Portugal, highlights her key priorities and the opportunities and challenges inherent in the fragmented Spanish healthcare system. Berra gives insight into the need for a bespoke rare disease focus and delivers advice to young women starting their journey in the healthcare industry.…

Spain Silvia Casellas, CEO of Anagram, a Spanish CRO, discusses the challenges of the consolidation process the company has gone in recent years, the reasons for the boom in Spain’s clinical trials ecosystem, and the importance of a close-knit client-to-service-provider relationship for CROs today.   We are the first Spanish company…

Spain Teresa Chavarria Gimenez, director general of planning, research and training at the Ministry of Health of the Community of Madrid, highlights her role and the BioMad initiative as they look to position Madrid on the European and global biotech map.   We want to facilitate the collaboration of the public…

Spain Rafael Mella, general manager of Nordic Pharma Spain & Portugal, highlights the steps he has taken to set-up the foundations for the company in the Spanish market and how he has overcome the challenges of the fragmented healthcare system. Furthermore, he gives insight into the Nordic’s game-changing Rheumatoid Arthritis product,…

Spain Alfonso García Cañamaque, CEO of León Research, gives an overview of the Spanish clinical research ecosystem and the challenges facing CROs. Also, he explains the differentiating factor of the company and internationalization strategy moving forward as they position themselves as the partner of choice.   One of our challenges is…

Spain Albert Barberá, director general of research and innovation in health for the Government of Catalonia, highlights his top priorities to facilitate the growth of the Catalan innovation scene and how he plans to transfer this to the healthcare system. Furthermore, he explains the importance of providing smaller companies with the…

Spain Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in place, Spain once again stands as one of Europe’s premier healthcare and life science investment destinations.   These fundamentals include a revamped market access process that puts the Iberian nation on a par…

Spain Cristina Garmendia, president of the Cotec Foundation, gives an overview of the innovation landscape in Spain and the steps needed to see this grow in the future. Furthermore, she gives advice based on her experiences with Genetrix, a company recently sold to Takeda, and she highlights what is next in…

Spain Javier Urzay, deputy director of Farmaindustria, gives an overview of the growth of the pharmaceutical sector in Spain and the challenges to find a balance between rewarding innovation and sustainability. Moreover, he talks about the development of clinical trials in Spain and the currently discussed new collaboration agreement with the…

Spain Angeles Delgado, president of Spain and Portugal for Fujitsu, a globally leading Japanese ICT company, discusses the long history of the company’s presence in Spain and within its healthcare system. Delgado goes on to shed light on the affiliate’s ongoing projects in Spain and how Fujitsu is positioning itself as…

Spain María Jesús Lamas, director and César Hernández García, head of medicines for human use at the Spanish Agency of Medicine and Health Products (AEMPS), discuss the challenges impacting the evaluation and analysis of products today. Furthermore, they give insights into why Spain is a leading global clinical trials destination and…

Spain Staffan Schüberg, CEO of Esteve, highlights the restructure of the company as it moves towards its new age of being a truly innovative pharmaceutical company on a global level. Furthermore, he highlights the international strategy and the role the US market will play in the future, as well as his…